Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Filter Results By

Filter Applied. Clear All
Reset All Filters

Search Results for: abortion pill

Abortion Pill Reversal: A Record of Safety and Efficacy

Chemical abortions have been increasing over recent years to now account for 44 percent of reported abortions in the United States in 2019.[1] These percentages have grown consistently from 6% in 2001 and will likely rise even faster as abortion providers pressure the Food and Drug Administration (F...

Overlooked Dangers of Mifepristone, the FDA’s Reduced REMS, and Self-Managed Abortion Policies: Unwanted Abortions, Unnecessary Abortions, Unsafe Abortions

The failure of abortion providers to support and undertake prospective longitudinal studies of a nationally representative sample of women contributes to our belief that the ideological biases of abortion providers have led to a combination of disinterest, willful ignorance, or even a conspiracy to ...

Handbook of Maternal Mortality: Addressing the U.S. Maternal Mortality Crisis, Looking Beyond Ideology

After years of failure to obtain accurate statistics on maternal mortality, researchers noted a sharp increase in the United States’ maternal mortality with widening racial disparities. Much discussion has followed about possible etiologies of the rise, but the existence of severe deficiencies in ...

Scientists Ask U.S. District Court to Suspend Sale of Dangerous, Poorly Tested Abortion Pills

With major international studies showing that the abortion pill regimen carries four times the risk of complications as surgical abortion, Charlotte Lozier Institute has filed an amicus brief asking the U.S. District Court for the Northern District of Texas to grant a preliminary injunction suspendi...

What is the Truth about the Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration lawsuit?

In response to the AHM v. FDA lawsuit, The New York Times (NYT) published an article they said proves definitively that abortion pills are “safe and effective.” This paper will address the limitations of the NYT’s conclusions and provide a framework for a thorough examination of the entirety o...

Dangerous Deception: Not Telling Your Doctor About Abortion Pill Use Increases Health Risks

A new analysis of 423,000 confirmed abortions debunks the common abortion industry narrative that “there’s no medical reason to tell a doctor about an abortion.”

Filed: CLI Amicus Brief in SCOTUS Case FDA v. Alliance for Hippocratic Medicine

On March 26, SCOTUS will hear oral arguments in the case FDA v. Alliance for Hippocratic Medicine. In the case, AHM argues that the FDA's changes to regulations of the abortion drug mifepristone were "arbitrary and capricious." CLI filed a brief in support of AHM, arguing that abortion with mifepris...

The Women’s Health Protection Act of 2013: The Sweeping Impact of S. 1696

If enacted in current form, S.1696 would jeopardize or outright invalidate a wide range of State and Federal abortion-related regulations.